IBD MD at University of Colorado. Clinician and researcher. Tweets my own. Retweet not endorsement.
Joined May 2018
- Tweets 523
- Following 262
- Followers 1,446
- Likes 869
65 Photos and videos
23 Jan 2025
‼️Important HBV reaction prevention in IBD pts. Note JAKi mod risk > aTNF in sAg(-), cAb( ) -> antiviral ppx. @GI_PharmD @JHashashMD @fudmanMD @Waseem_AhmedMD @IBDPharmD
gastrojournal.org/article/S0…
30
71
7,205
15 Jan 2025
Crowdsourcing IBD journal club ideas. What are your biggest clinical impact recent articles? @fudmanMD @DCharabaty @IBDimmunology @Waseem_AhmedMD @EdwardLoftus2 @MLongMD @Bealoquebea
8
2
21
3,866
Ben Click retweeted
2 Dec 2024
Maybe time to just get the C diff test?
3 May 2023
The first RCT of GI-PCR for acute diarrhea
👎more antibiotic use in PCR arm
👉no difference in any outcome
🤷♂️less time in isolation for PCR arm
This test is 💩, friends
Instead:
Supportive care
Test sparingly
Mostly cdiff
thelancet.com/action/showPdf…
1
4
23
6,840
27 Nov 2024
Makes sense and highlights 💊💉needs after ASUC 🏥, but still high (~50%) rate of “treatment failure” in IVCS responsive -> IFX AZA. ? rapid steroid taper in IFX. ? No proactive TDM in high risk pop. Other thoughts? @Waseem_AhmedMD @berinsj @IBDimmunology
3
2
8
2,642
Ben Click retweeted
19 Nov 2024
🚨AGA New Guideline Alert🚨
🔗gastrojournal.org/article/S0…
▶️AGA Living Guideline: Pharmacological Management of Moderate-Severe Ulcerative Colitis
I’ll break down its 14 recommendations down over the next 7 tweets 🧵 👇
#AGA #GI #UC #IBD #MedTwitter
1/9
9
106
325
38,797
19 Nov 2024
First non aTNF to demonstrate efficacy in RCT to 🛑 endo recurrence. Good option and reassuring data to have.
19 Nov 2024
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa…
4
27
1,847
Ben Click retweeted
14 Nov 2024
More RWE that combo-AT effective in refractory IBD (n=79) @jensemineriomd
🟢Mean Mayo 3▶️1
🟢Mean SES-CD 12▶️4
🟢73% clin improvement
🔴47% AEs (URIs and derm issues mostly)
bit.ly/4fm80WI
2
11
931
Ben Click retweeted
30 Oct 2024
@ABennettMD did an amazing job at #ACG2024 presenting a multi-center study evaluating outcomes in transgender pts with IBD on gender affirming hormones!
@VUMCibd @VictorChedidMD @KiraNewmanMDPhD @JustinFieldMD @BenClickMD
2
10
538
Ben Click retweeted
5 Sep 2024
🚨Fellows & jr attendings- Don't miss this on 9/18!
1⃣Find & negotiate your first or next GI/#IBD job, academic or community
2⃣Navigate career transitions or move to leadership
3⃣Q&A with those in the know
@drharrythomas @Marylandibddoc @JillGaidosMD @BenClickMD
Sign up 👇
2
16
40
6,922
Ben Click retweeted
It’s a packed 🏡 at #RMH2024! We are so thankful 🙌 for all of our amazing attendees and supporters for coming out bright ⭐️ and early 🌞on this Saturday!
4
13
1,134
4 Aug 2024
Ever wonder if you should biopsy normal neoTI after resection in CD?
▶️Normal (i0) endoscopy
▶️Active inflammation
⬆️POR risk
More evidence that active 🔬 disease can risk stratify IBD clinical risk. @RavShahMD @IBDBen @DrJordanAxelrad @EdBarnesMD
journals.lww.com/ajg/abstrac…
3
16
43
3,997
4 Aug 2024
What to do clinically with this info?
▶️Start/change meds?
Probably not…yet
▶️Closer monitoring?
I benchmark FC and then follow q3m with repeat CSY in one yr (or rising FC). IUS could be nice interval data here.
1
9
433
17 Jul 2024
Kudos to @HolubarStefan for the excellent mesenteric landscape breakdown. SPICY trial an important addition, but still many unknowns in “trimming the Crohn’s fat” @CUGastroHep @ClevelandClinic
Linked Comment - Click & Holubar - Targeting the mesentery with surgery in ileocolic Crohn's disease: where do we stand?
thelancet.com/journals/langa…
#GITwitter #IBD @BenClickMD @HolubarStefan
9
17
2,306
Ben Click retweeted
15 Jul 2024
Hot of the press: Upadacitinib safety in pregnancy. 128 maternal pregnacies all exposed in the first trimester primarily. @MotherToBaby @JulsgaardMette @MLongMD link.springer.com/article/10…
5
69
176
21,629
Ben Click retweeted
It’s dope to scope! 🤣First year fellows start scoping right away on inpatient consult services and on outpatient endo blocks. Follow our fellows on instagram @colorado_gi #futureofgi #gifellowship #gifellows #gastroenterology #academicgi
2
37
2,111
11 Jul 2024
Thanks to @ShomronH for phenomenal talk on role of VCE - practice changing evidence from master clinician, researcher, and world traveler.
11 Jul 2024
Cool session at @CUGastroHep discussing use of #VCE in monitoring CD.
Had great time with
@MarkGerichMD (who ran off to scope before the pic was taken...)
@FrankIScottMD @BenClickMD @Waseem_AhmedMD
And the rest of fantastic U.Colorado team
2
18
2,029
Ben Click retweeted
18 May 2024
#TaylorKarl with an outstanding presentation evaluating the cost-effectiveness of #calprotectin in post-op #CD monitoring. @BenClickMD @FrankIScottMD @IBDBen @DrJordanAxelrad @MRegueiroMD #DDW2024
7
29
2,363
Ben Click retweeted
18 May 2024
Taylor Karl presenting our modeling data suggesting that fecal calprotectin monitoring reduces costs and improves quality of life in comparison to colonoscopic assessment in low risk post operative CD, supporting recently published guideline revisions @BenClickMD @CUGastroHep
3
17
646
22 Apr 2024
37 yoM non-smoker, dx w stricturing ileal CD. Started on ADAL x1 yr then ICR ✂️for symptomatic 10 cm stricture.
🔬Path: Chronic active ileitis, margins clear.
#MondayNightIBD What is your medical and monitoring post-op plan?
42%
Meds CSY in 6-12 mo
18%
Meds FCP/IUS in 6-12 mo
29%
No Meds CSY in 6-12 mo
12%
No Meds FCP/IUS 6-12 mo
129 votes • Final results
5
9
21
8,698
22 Apr 2024
If planning postop meds, which one do you choose?
31%
ADAL
21%
IFX
34%
USTE/RISA
14%
VDZ
77 votes • Final results
2
2
6
680
22 Apr 2024
How do you decide to stick with a pre🔪 💉 or change agents, MOAs?
3
171
22 Apr 2024
For those that choose💉prophylaxis, what risk factors or 💭drove that decision?
Who's doing non-invasive monitoring only? When and how often do you perform?
1
2
7
772